The World Bladder Cancer Patient Coalition (WBCPC) was proud to take part in the Global Cancer Coalitions Network (GCCN) Annual Meeting in Toronto, Canada, on August 28-29, 2024. WBCPC joined GCCN in 2020, with our Executive Director Alex Filicevas currently Co-Chairing the initiative. This annual event brought together leading cancer patient advocacy coalitions from around the world to explore ways to collaborate and share expertise to improve patient outcomes and strengthen advocacy efforts globally.
News & Events Category: EVENTS
Annual IBCG Retreat shaping global bladder cancer care
The World Bladder Cancer Patient Coalition (WBCPC) had the honour to join the International Bladder Cancer Group (IBCG) Retreat in Houston, Texas (USA). This important event brought together experts from around the world to develop new recommendations for managing bladder cancer. These guidelines will help shape clinical decisions for doctors and improve care for people affected by bladder cancer.
Representing WBCPC at the retreat were our President, Dr Lydia Makaroff, and Executive Director,
Save your seat – World Bladder Cancer Patient Forum
We saved you a seat at the World Bladder Cancer Patient Forum 2024 on October 1-2 in Punta Cana, Dominican Republic.
If you can’t join us in person, you will have the opportunity to follow the event online – so do make sure to register today!
This year, we will dive deeper into the impact of bladder cancer in Latin America and the patient advocacy landscape,
SAVE THE DATE – World Bladder Cancer Patient Forum 2024
We are thrilled to announce that the World Bladder Cancer Patient Forum 2024 will take place on October 1-2, in Punta Cana, Dominican Republic! We invite you to Save The Date and hope to see you there in person.
This year we will once again bring the global bladder cancer patient community together for two days of important discussions, learnings, sharing ideas, and networking.
If you have missed last year’s and/or would like to revisit the discussions,
Bladder cancer research highlights from EAU24
The European Association of Urology 2024 (EAU24) is Europe’s largest Annual Urology Congress which took place on April 5-8, in Paris, France.
We have selected three bladder cancer research studies presented at EAU24, with lay summaries of each study provided below.
Localised chemotherapy for people with high-risk, non-muscle-invasive bladder cancer
The SunRISe-1 study is evaluating the effectiveness and safety of TAR-200, a new treatment for people with high-risk non-muscle-invasive bladder cancer who found that standard BCG treatment didn’t work for them and who are unable to have surgery (cystectomy).
Bladder Cancer Patient Day in France to help patients take control
Cancer Vessie France, a member of WBCPC, has again teamed up with the French Association of Urology (AFU) to raise awareness about bladder cancer in May. Attendees, including patients, caregivers, healthcare professionals, and researchers, gathered from across France to deepen their understanding of bladder cancer and its impacts.
This year’s Patient Day took place on 2nd May, during Bladder Cancer Awareness Month 2024. The meeting offered comprehensive information tailored to patients,
Connecting with urology professionals at EAU24
Our secretariat team and several WBCPC Board Members attended the European Association of Urology 2024 (EAU24) Congress in Paris, France which took place during 5-8 April. During this event, we hosted a booth where we invited urologists, allied healthcare professionals, patients and others in attendance to learn more about the World Bladder Cancer Patient Coalition and our member organisations.
During the congress, we had the opportunity to talk with visitors from different countries about the results of our Global Bladder Cancer Patient &
Empowering patient care with AI: WBCPC presentation at EAU24
WBCPC President, Dr Lydia Makaroff, presented on the use of digital technology and data-driven shared decision-making at the European Association of Urology 2024 (EAU24), Europe’s largest Annual Urology Congress, in Paris, France this week.
Her presentation focused on how new technologies and AI, in particular, are reshaping the way patients and doctors work together to make health decisions. During her presentation, she discussed the impact of digital tools on patients through 3 case studies:
- Educational modules for patient organisation: In collaboration with Stanford University,
Bladder cancer research highlights from ASCO GU 2024
ASCO Genitourinary Cancer Symposium is the leading annual meeting organised by the American Society of Clinical Oncology on January 25-27, 2024. It focuses on genitourinary cancers and scientific research in this field. We have selected four bladder cancer research studies presented at ASCO GU, with lay summaries of each study provided below.
This year, World Bladder Cancer Patient Coalition (WBCPC) also marked a significant achievement by presenting the Global Bladder Cancer Patient &
WBCPC Patient survey findings at ASCO GU Symposium in San Francisco
The World Bladder Cancer Patient Coalition (WBCPC) marked a significant achievement by presenting the Global Bladder Cancer Patient & Carer Survey results poster at the ASCO Genitourinary Cancers Symposium in San Francisco, California (USA). The leading annual meeting organised by the American Society of Clinical Oncology on January 25-27, 2024. This marked the organisation’s first poster at this prestigious event, underscoring our growing commitment and impact in the field of bladder cancer research and advocacy.
